Clinical Trials Directory

Trials / Completed

CompletedNCT00636220

Evaluation of the DPP HIV 1/2 Test and the HIV 1/2 Stat Pak Test Using Oral Fluid

Evaluation of the DPP HIV Test With Reader and the HIV 1/2 Stat-Pak Test Using Oral Fluids

Status
Completed
Phase
Study type
Observational
Enrollment
101 (actual)
Sponsor
Chembio Diagnostic Systems, Inc. · Industry
Sex
All
Age
12 Years
Healthy volunteers
Not accepted

Summary

This protocol is intended to test the feasibility of using the HIV 1/2 STAT-PAK and the DPP HIV 1/2 test (with and without the DPP Handheld Reader) to detect HIV antibodies in oral fluids.

Detailed description

The objective of this study is to evaluate the feasibility of using fresh oral fluid specimens, from known HIV-positive individuals, to test for HIV-1 antibodies using both the DPP HIV 1/2 and HIV 1/2 STAT-PAK tests. Two oral fluid collection devices will be used and compared (MPC and Chembio collection devices) and the results obtained from oral fluids will be compared with those obtained from whole blood and plasma using paired samples from the same participants. The comparison between oral fluid, whole blood and plasma will be made in both Chembio devices (HIV 1/2 STAT-PAK and DPP HIV 1/2).

Conditions

Timeline

Start date
2008-03-01
Primary completion
2008-07-01
Completion
2008-07-01
First posted
2008-03-14
Last updated
2015-08-17
Results posted
2010-02-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00636220. Inclusion in this directory is not an endorsement.